Responsible and Compliant Data Sharing Between Diagnostics and Pharmaceutical Companies
Health data is more valuable when shared. This is the view of leading genetic testing companies that are pushing the boundaries to improve human health outcomes and accelerate research with clinico-genomic data. Yet from the perspective of pharmaceutical companies, there is significant exposure to sharing data with third-party partners. Compliance with Quality System Regulations (QSRs) -- also known as GxP compliance—is critical to operating in this heavily regulated environment. Pharma companies and their diagnostic partners are required to meet these QSRs. DNAnexus’ approach simplifies QSR compliance for diagnostics companies, freeing them to focus on building and expanding the value of genetic tests—rather than worry about regulatory compliance.
In this White Paper:
- An overview of the FDA’s Quality System Regulations (QSR) and GxP guidelines
- How to comply with QSRs to land strategic pharma partnerships
- How partners like DNAnexus can help your company build and support compliant global collaborations
DNAnexus Titan is a cloud-based informatics environment that brings data and pipelines together in one place for streamlined omics analysis. DNAnexus Titan powers rapid scaling to meet increasing volume demands, grow your test portfolio, and simplify the complexities of secondary genomic analysis infrastructure, allowing your team to focus on what’s important — delivering test results. Learn more.
DNAnexus is the trusted partner to Life Science, Healthcare, Government, and Academia in over 48 countries, and serves the world’s top pharmaceutical companies and national research initiative.